Chen Xiao-Fei, Zhao Xin, Yang Zifeng
Guangdong Provincial Key Laboratory of Emergency Test for Dangerous Chemicals, Institute of Analysis, Guangdong Academy of Sciences (China National Analytical Center, Guangzhou), Guangzhou 510070, PR China.
State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510120, PR China.
J Med Chem. 2021 Dec 23;64(24):17601-17626. doi: 10.1021/acs.jmedchem.1c01567. Epub 2021 Dec 2.
Nucleic acid aptamers are single-stranded DNA or RNA molecules selected that can bind to a broad range of targets with high affinity and specificity. As promising alternatives to conventional anti-infective agents, aptamers have gradually revealed their potential in the combat against infectious diseases. This article provides an overview on the state-of-art of aptamer-based antibacterial and antiviral therapeutic strategies. Diverse aptamers targeting pathogen-related components or whole pathogenic cells are summarized according to the species of microorganisms. These aptamers exhibited remarkable and/or inhibitory effect for pathogenic invasion, enzymatic activities, or viral replication, even for some highly drug-resistant strains and biofilms. Aptamer-mediated drug delivery and controlled drug release strategies are also included herein. Critical technical barriers of therapeutic aptamers are briefly discussed, followed by some future perspectives for their implementation into clinical utility.
核酸适体是经过筛选的单链DNA或RNA分子,能够以高亲和力和特异性结合多种靶标。作为传统抗感染药物的有前景的替代物,适体在对抗传染病方面逐渐展现出其潜力。本文综述了基于适体的抗菌和抗病毒治疗策略的最新进展。根据微生物种类总结了针对病原体相关成分或整个致病细胞的多种适体。这些适体对病原体入侵、酶活性或病毒复制表现出显著的抑制作用,甚至对一些高度耐药菌株和生物膜也有作用。本文还包括适体介导的药物递送和控释策略。简要讨论了治疗性适体的关键技术障碍,随后对其临床应用的未来前景进行了一些展望。